3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Rhabdomyosarcoma
1
Osteosarcoma
1
Neuroblastoma
1
Interventions
Cyclophosphamide
23
Temozolomide
14
Filgrastim
13
Irinotecan
12
Melphalan
11
Etoposide
10
Carboplatin
9
Vincristine
8
Peripheral Blood Stem Cell Transplantation
8
Granulocyte Colony-Stimulating Factor
8
X-Rays
7
Topotecan
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Busulfan
7
fludarabine
6
Thiotepa
6
Phantoms, Imaging
6
fludarabine phosphate
5
Radiotherapy
5
Biopsy
5
Antilymphocyte Serum
5
Oxaliplatin
4
Nuclear Medicine Department, Hospital
4
Nivolumab
4
Methylprednisolone
4
Ifosfamide
4
Cisplatin
4
palbociclib
3
olaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroblastoma
×
MAGEA3 protein, human
×
Sarcoma
×
Clear all
NCT00944580
2017-11-24
A Vaccine Study for High Risk Cancers
Penn State University
Phase 1
Withdrawn